The link between lipids, statins and cancer: is there a role for cardio-oncology?

Future Cardiol. 2015 Jul;11(4):389-93. doi: 10.2217/FCA.15.32. Epub 2015 Aug 4.

Authors

Eiman Jahangir¹, Nichole M Polin¹, Carl J Lavie¹, Sergio Fazio²

Affiliations

¹ John Ochsner Heart & Vascular Institute, Ochsner Clinical School, The University of Queensland School of Medicine, 1514 Jefferson Highway, New Orleans, LA 70121, USA.
² Center for Preventive Cardiology, Oregon Health & Science University; 3181 Sam Jackson Park Road, Portland, OR 97239, USA.

PMID: 26239431
DOI: 10.2217/FCA.15.32

No abstract available

Keywords: HMG-CoA reductase inhibitors; cancer; cardio-oncology; cholesterol; lipids; statins.

MeSH terms

Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Hyperlipidemias / complications*
Hyperlipidemias / drug therapy
Neoplasms / epidemiology*

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors